FDA — authorised 20 February 1953
- Marketing authorisation holder: HOSPIRA
- Status: approved
FDA authorised Infuvite Adult on 20 February 1953
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 20 February 1953.
HOSPIRA holds the US marketing authorisation.